Developing point-of-care CAR T manufacturing
European Pharmaceutical Review
DECEMBER 27, 2023
Considerations for in-house CAR facilities When establishing a point-of-care CAR facility, there are several initial considerations that must be addressed. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.
Let's personalize your content